AACR Pipeline Drugs - Some ASPS data Cediranib, Foretinib

[Fictional]

Came across the abstracts:
http://www.modernmedicine.com/modernmed ... ryId=40159


3 abstractions mention ASPS by name:

A4: Avastin and Cediranib - one ASPS patient had a partial response RECIST of 24%

A5: Dosing trial of Cediranib in kids - similar side effect profile as adults, better if lower dose titrated up rather than starting high.

A78 Foretinib: Oral met inhibitor + VEGFR2 inhibitor. ASPS was 'event-free' at 12 months (I think that means stable).

[Olga]

Thanks 'F' for the lead. This article is about the proceeding of the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics 2009 conference (Nov.15-19)
The proceeding of the conference are available at the AACR web-site
http://www.aacr.org/home/scientists/mee ... racts.aspx

with the above mentioned posters in the Angiogenesis and Antiangiogenesis Agents 1 POSTER SESSION A
http://www.aacr.org/Uploads/DocumentRep ... osterA.pdf